PGS Sample Set (PSS) large_stringlengths 9 9 | Polygenic Score (PGS) ID large_stringlengths 9 2.77k | Number of Individuals int64 1 5.33M | Number of Cases float64 0 389k ⌀ | Number of Controls float64 0 1.14M ⌀ | Percent of Participants Who are Male float64 0 100 ⌀ | Sample Age large_stringclasses 733
values | Broad Ancestry Category large_stringclasses 73
values | Ancestry (e.g. French, Chinese) large_stringclasses 90
values | Country of Recruitment large_stringclasses 140
values | Additional Ancestry Description large_stringclasses 131
values | Phenotype Definitions and Methods large_stringclasses 798
values | Followup Time large_stringclasses 141
values | GWAS Catalog Study ID (GCST...) large_stringclasses 8
values | Source PubMed ID (PMID) float64 1.25M 39.9M ⌀ | Source DOI large_stringclasses 13
values | Cohort(s) large_stringclasses 460
values | Additional Sample/Cohort Information large_stringclasses 245
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSS000529 | PGS000006 | 2,088 | 297 | 1,791 | 0 | null | European | null | UK, netherlands, France, Canada, Denmark, Sweden, Australia, New zealand, and more. | null | Eligibility was restricted to female BRCA1 and BRCA2 carriers who at completion of the baseline questionnaire were free of any cancer diagnosis (excluding non-melanoma skin cancer) and had not undergone risk-reducing bilateral mastectomy. Participants diagosed with a first breast cancer were considered affected. | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|BCFR|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OC... | null |
PSS000530 | PGS000352 | 3,152 | 108 | 3,044 | 0 | null | European | null | UK, netherlands, France, Canada, Denmark, Sweden, Australia, New zealand, and more. | null | To assess associationss between the PRS and ovarian cancer risk, eligibility was restricted to women who had not been diagnosed with ovarian cancer and had not had RRSO at the time of baselinne questionnaire completion. Carriers diagnosed with invasive ovarian, fallopian tube, or peritoneal cancer during the follow-up ... | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|BCFR|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OC... | null |
PSS000531 | PGS000004 | 1,757 | 215 | 1,542 | 0 | null | European | null | UK, netherlands, France, Canada, Denmark, Sweden, Australia, New zealand, and more. | null | Eligibility was restricted to female BRCA1 and BRCA2 carriers who at completion of the baseline questionnaire were free of any cancer diagnosis (excluding non-melanoma skin cancer) and had not undergone risk-reducing bilateral mastectomy. Participants diagosed with a first breast cancer were considered affected. | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|BCFR|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OC... | null |
PSS000532 | PGS000352 | 2,495 | 56 | 2,439 | 0 | null | European | null | UK, netherlands, France, Canada, Denmark, Sweden, Australia, New zealand, and more. | null | To assess associationss between the PRS and ovarian cancer risk, eligibility was restricted to women who had not been diagnosed with ovarian cancer and had not had RRSO at the time of baseline questionnaire completion. Carriers diagnosed with invasive ovarian, fallopian tbe, or peritoneal cancer during the follow-up we... | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|BCFR|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OC... | null |
PSS000533 | PGS000353, PGS000354, PGS000355, PGS000356 | 15,286 | 10,394 | 4,892 | null | null | European | null | USA | null | Any Cancer PheCode | null | null | 32,991,828 | null | MGI | null |
PSS000534 | PGS000359 | 2,841 | 259 | 2,582 | null | null | European | null | USA | null | PheCode:145.2; ICD9CM:141.0, 141.1, 141.2, 141.3, 141.4, 141.5, 141.6, 141.8, 141.9, V10.01; ICD10CM:C01, C02, C02.0, C02.1, C02.2, C02.3, C02.4, C02.8, C02.9 | null | null | 32,991,828 | null | MGI | null |
PSS000535 | PGS000357, PGS000358 | 6,328 | 578 | 5,750 | null | null | European | null | USA | null | PheCode:145; ICD9CM:140.0, 140.1, 140.3, 140.4, 140.5, 140.6, 140.8, 140.9, 141.0, 141.1, 141.2, 141.3, 141.4, 141.5, 141.6, 141.8, 141.9, 142.0, 142.1, 142.2, 142.8, 142.9, 143.0, 143.1, 143.8, 143.9, 144.0, 144.1, 144.8, 144.9, 145.0, 145.1, 145.2, 145.3, 145.4, 145.5, 145.6, 145.8, 145.9, 230.0, V10.01; ICD10CM:C00,... | null | null | 32,991,828 | null | MGI | null |
PSS000536 | PGS000360, PGS000361, PGS000362 | 1,738 | 158 | 1,580 | null | null | European | null | USA | null | PheCode:149.4; ICD9CM:161.0, 161.1, 161.2, 161.3, 161.8, 161.9, 231.0, V10.21; ICD10CM:C32, C32.0, C32.1, C32.2, C32.3, C32.8, C32.9, D02.0 | null | null | 32,991,828 | null | MGI | null |
PSS000537 | PGS000363, PGS000364, PGS000365, PGS000366 | 2,064 | 188 | 1,876 | null | null | European | null | USA | null | PheCode:150; ICD9CM:150.0, 150.1, 150.2, 150.3, 150.4, 150.5, 150.8, 150.9, 230.1, V10.03; ICD10CM:C15, C15.3, C15.4, C15.5, C15.8, C15.9, D00.1 | null | null | 32,991,828 | null | MGI | null |
PSS000538 | PGS000376, PGS000377, PGS000378, PGS000379, PGS000380, PGS000381, PGS000382 | 5,031 | 462 | 4,569 | null | null | European | null | USA | null | PheCode:153.2; ICD9CM:153.0, 153.1, 153.2, 153.3, 153.4, 153.5, 153.6, 153.7, 153.8, 153.9, 159.0, 209.10, 209.11, 209.12, 209.13, 209.14, 209.15, 209.16, 230.3, V10.05; ICD10CM:C18, C18.0, C18.1, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C18.9, C26.0, C7A.020, C7A.021, C7A.022, C7A.023, C7A.024, C7A.025, C7A.02... | null | null | 32,991,828 | null | MGI | null |
PSS000539 | PGS000383, PGS000384 | 3,557 | 325 | 3,232 | null | null | European | null | USA | null | PheCode:153.3; ICD9CM:154.0, 154.1, 154.2, 154.3, 209.17, 230.4, 230.5, 230.6, 796.70, 796.71, 796.72, 796.73, 796.74, 796.76, V10.06; ICD10CM:C19, C20, C21.0, C21.1, C7A.026, D01.1, D01.2, D01.3, R85.610, R85.611, R85.612, R85.613, R85.614, R85.619 | null | null | 32,991,828 | null | MGI | null |
PSS000540 | PGS000367, PGS000369, PGS000373, PGS000374, PGS000375 | 6,633 | 607 | 6,026 | null | null | European | null | USA | null | PheCode:153; ICD9CM:153.0, 153.1, 153.2, 153.3, 153.4, 153.5, 153.6, 153.7, 153.8, 153.9, 154.0, 154.1, 154.2, 154.3, 154.8, 159.0, 209.10, 209.11, 209.12, 209.13, 209.14, 209.15, 209.16, 209.17, 230.3, 230.4, 230.5, 230.6, 796.70, 796.71, 796.72, 796.73, 796.74, 796.76, V10.05, V10.06; ICD10CM:C18, C18.0, C18.1, C18.2... | null | null | 32,991,828 | null | MGI | null |
PSS000541 | PGS000388, PGS000389, PGS000391, PGS000393, PGS000394, PGS000395, PGS000396, PGS000397 | 4,698 | 428 | 4,270 | null | null | European | null | USA | null | PheCode:165.1; ICD9CM:162.0, 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 209.21, 231.2, V10.11; ICD10CM:C33, C34, C34.0, C34.00, C34.01, C34.02, C34.1, C34.10, C34.11, C34.12, C34.2, C34.3, C34.30, C34.31, C34.32, C34.8, C34.80, C34.81, C34.82, C34.9, C34.90, C34.91, C34.92, C7A.090, D02.2, D02.20, D02.21, D02.22 | null | null | 32,991,828 | null | MGI | null |
PSS000542 | PGS000387 | 5,218 | 475 | 4,743 | null | null | European | null | USA | null | PheCode:165; ICD9CM:162.0, 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 163.0, 163.1, 163.8, 163.9, 165.0, 165.8, 165.9, 209.21, 231.1, 231.2, 231.8, 231.9, V10.11, V10.12, V10.20, V10.29; ICD10CM:C33, C34, C34.0, C34.00, C34.01, C34.02, C34.1, C34.10, C34.11, C34.12, C34.2, C34.3, C34.30, C34.31, C34.32, C34.8, C34.80, C... | null | null | 32,991,828 | null | MGI | null |
PSS000543 | PGS000408, PGS000409, PGS000410, PGS000411, PGS000412, PGS000413, PGS000414, PGS000415, PGS000416, PGS000417, PGS000418, PGS000419, PGS000420, PGS000421, PGS000423, PGS000425, PGS000427, PGS000429, PGS000430, PGS000431, PGS000432 | 11,974 | 1,325 | 10,649 | null | null | European | null | USA | null | PheCode:172.1; ICD9CM:172.0, 172.1, 172.2, 172.3, 172.4, 172.5, 172.6, 172.7, 172.8, 172.9, V10.82; ICD10CM:C43, C43.0, C43.1, C43.10, C43.11, C43.12, C43.2, C43.20, C43.21, C43.22, C43.3, C43.30, C43.31, C43.39, C43.4, C43.5, C43.51, C43.52, C43.59, C43.6, C43.60, C43.61, C43.62, C43.7, C43.70, C43.71, C43.72, C43.8, ... | null | null | 32,991,828 | null | MGI | null |
PSS000544 | PGS000445, PGS000446, PGS000447, PGS000448, PGS000449, PGS000450, PGS000451, PGS000452, PGS000454, PGS000456, PGS000458 | 11,322 | 1,481 | 9,841 | null | null | European | null | USA | null | PheCode:172.21; ICD9CM:173.01, 173.11, 173.21, 173.31, 173.41, 173.51, 173.61, 173.71, 173.81, 173.91; ICD10CM:C44.01, C44.111, C44.112, C44.119, C44.211, C44.212, C44.219, C44.310, C44.311, C44.319, C44.41, C44.510, C44.511, C44.519, C44.611, C44.612, C44.619, C44.711, C44.712, C44.719, C44.81, C44.91 | null | null | 32,991,828 | null | MGI | null |
PSS000545 | PGS000460, PGS000461, PGS000463, PGS000465, PGS000467 | 8,473 | 982 | 7,491 | null | null | European | null | USA | null | PheCode:172.22; ICD9CM:173.02, 173.12, 173.22, 173.32, 173.42, 173.52, 173.62, 173.72, 173.82, 173.92; ICD10CM:C44.02, C44.121, C44.122, C44.129, C44.221, C44.222, C44.229, C44.320, C44.321, C44.329, C44.42, C44.520, C44.521, C44.529, C44.621, C44.622, C44.629, C44.721, C44.722, C44.729, C44.82, C44.92 | null | null | 32,991,828 | null | MGI | null |
PSS000546 | PGS000433, PGS000434, PGS000435, PGS000436, PGS000437, PGS000438, PGS000439, PGS000440, PGS000441, PGS000442, PGS000443, PGS000444 | 15,898 | 2,954 | 12,944 | null | null | European | null | USA | null | PheCode:172.2; ICD9CM:173.00, 173.01, 173.02, 173.09, 173.10, 173.11, 173.12, 173.19, 173.20, 173.21, 173.22, 173.29, 173.30, 173.31, 173.32, 173.39, 173.40, 173.41, 173.42, 173.49, 173.50, 173.51, 173.52, 173.59, 173.60, 173.61, 173.62, 173.69, 173.70, 173.71, 173.72, 173.79, 173.80, 173.81, 173.82, 173.89, 173.90, 17... | null | null | 32,991,828 | null | MGI | null |
PSS000547 | PGS000469, PGS000470, PGS000471 | 5,500 | 585 | 4,915 | null | null | European | null | USA | null | PheCode:172.3; ICD9CM:232.0, 232.1, 232.2, 232.3, 232.4, 232.5, 232.6, 232.7, 232.8, 232.9; ICD10CM:D04, D04.0, D04.1, D04.10, D04.11, D04.12, D04.2, D04.20, D04.21, D04.22, D04.3, D04.30, D04.39, D04.4, D04.5, D04.6, D04.60, D04.61, D04.62, D04.7, D04.70, D04.71, D04.72, D04.8, D04.9 | null | null | 32,991,828 | null | MGI | null |
PSS000548 | PGS000398, PGS000399, PGS000400, PGS000401, PGS000402, PGS000403, PGS000404, PGS000405, PGS000406, PGS000407 | 17,607 | 3,557 | 14,050 | null | null | European | null | USA | null | PheCode:172; ICD9CM:172.0, 172.1, 172.2, 172.3, 172.4, 172.5, 172.6, 172.7, 172.8, 172.9, 173.00, 173.01, 173.02, 173.09, 173.10, 173.11, 173.12, 173.19, 173.20, 173.21, 173.22, 173.29, 173.30, 173.31, 173.32, 173.39, 173.40, 173.41, 173.42, 173.49, 173.50, 173.51, 173.52, 173.59, 173.60, 173.61, 173.62, 173.69, 173.70... | null | null | 32,991,828 | null | MGI | null |
PSS000549 | PGS000472, PGS000473, PGS000474, PGS000475, PGS000476, PGS000477, PGS000478, PGS000479, PGS000480, PGS000481, PGS000482, PGS000483, PGS000484, PGS000485, PGS000487, PGS000489, PGS000491, PGS000493, PGS000495, PGS000497, PGS000499, PGS000501, PGS000503, PGS000505, PGS000507, PGS000509, PGS000511, PGS000513, PGS000514, P... | 7,785 | 1,341 | 6,444 | null | null | European | null | USA | null | PheCode:174.1; ICD9CM:174.0, 174.1, 174.2, 174.3, 174.4, 174.5, 174.6, 174.8, 174.9, 233.0, V10.3; ICD10CM:C50, C50.0, C50.01, C50.011, C50.012, C50.019, C50.02, C50.021, C50.022, C50.029, C50.1, C50.11, C50.111, C50.112, C50.119, C50.12, C50.121, C50.122, C50.129, C50.2, C50.21, C50.211, C50.212, C50.219, C50.22, C50.... | null | null | 32,991,828 | null | MGI | null |
PSS000550 | PGS000559, PGS000561 | 1,904 | 174 | 1,730 | null | null | European | null | USA | null | PheCode:184.11; ICD9CM:183.0, V10.43; ICD10CM:C56, C56.1, C56.2, C56.9 | null | null | 32,991,828 | null | MGI | null |
PSS000551 | PGS000543 | 4,905 | 453 | 4,452 | null | null | European | null | USA | null | PheCode:184; ICD9CM:181, 183.0, 183.2, 183.3, 183.4, 183.5, 183.8, 183.9, 184.0, 184.1, 184.2, 184.3, 184.4, 184.8, 184.9, 233.30, 233.31, 233.32, 233.39, 236.0, 236.1, 236.2, 236.3, V10.40, V10.43, V10.44; ICD10CM:C51, C51.0, C51.1, C51.2, C51.8, C51.9, C52, C56, C56.1, C56.2, C56.9, C57, C57.0, C57.00, C57.01, C57.02... | null | null | 32,991,828 | null | MGI | null |
PSS000552 | PGS000565, PGS000566, PGS000567, PGS000568, PGS000569, PGS000570, PGS000571, PGS000572, PGS000573, PGS000574, PGS000575, PGS000576, PGS000577, PGS000579, PGS000581, PGS000583, PGS000585, PGS000587, PGS000589, PGS000590, PGS000591, PGS000592 | 5,607 | 1,190 | 4,417 | null | null | European | null | USA | null | PheCode:185; ICD9CM:185, 233.4, V10.46; ICD10CM:C61, D07.5 | null | null | 32,991,828 | null | MGI | null |
PSS000553 | PGS000595, PGS000596, PGS000597, PGS000598, PGS000599, PGS000600, PGS000601, PGS000603 | 755 | 73 | 682 | null | null | European | null | USA | null | PheCode:187.2; ICD9CM:186.0, 186.9, V10.47; ICD10CM:C62, C62.0, C62.00, C62.01, C62.02, C62.1, C62.10, C62.11, C62.12, C62.9, C62.90, C62.91, C62.92 | null | null | 32,991,828 | null | MGI | null |
PSS000554 | PGS000593, PGS000594 | 1,490 | 137 | 1,353 | null | null | European | null | USA | null | PheCode:187; ICD9CM:186.0, 186.9, 187.1, 187.2, 187.3, 187.4, 187.5, 187.6, 187.7, 187.8, 187.9, 233.5, 233.6, 236.4, 236.5, 236.6, V10.45, V10.47, V10.48, V10.49; ICD10CM:C60, C60.0, C60.1, C60.2, C60.8, C60.9, C62, C62.0, C62.00, C62.01, C62.02, C62.1, C62.10, C62.11, C62.12, C62.9, C62.90, C62.91, C62.92, C63, C63.0... | null | null | 32,991,828 | null | MGI | null |
PSS000555 | PGS000607, PGS000608, PGS000609, PGS000610, PGS000612, PGS000614, PGS000615, PGS000616 | 7,622 | 789 | 6,833 | null | null | European | null | USA | null | PheCode:189.2; ICD9CM:188.0, 188.1, 188.2, 188.3, 188.4, 188.5, 188.6, 188.7, 188.8, 188.9, 233.7, 236.7, 239.4, V10.51; ICD10CM:C67, C67.0, C67.1, C67.2, C67.3, C67.4, C67.5, C67.6, C67.7, C67.8, C67.9, D09.0, D41.4, D49.4 | null | null | 32,991,828 | null | MGI | null |
PSS000556 | PGS000617 | 672 | 62 | 610 | null | null | European | null | USA | null | PheCode:190; ICD9CM:190.0, 190.1, 190.2, 190.3, 190.4, 190.5, 190.6, 190.7, 190.8, 190.9, 234.0, V10.84; ICD10CM:C69, C69.0, C69.00, C69.01, C69.02, C69.1, C69.10, C69.11, C69.12, C69.2, C69.20, C69.21, C69.22, C69.3, C69.30, C69.31, C69.32, C69.4, C69.40, C69.41, C69.42, C69.5, C69.50, C69.51, C69.52, C69.6, C69.60, C... | null | null | 32,991,828 | null | MGI | null |
PSS000557 | PGS000620, PGS000621, PGS000623, PGS000625 | 2,563 | 233 | 2,330 | null | null | European | null | USA | null | PheCode:191.11; ICD9CM:191.0, 191.1, 191.2, 191.3, 191.4, 191.5, 191.6, 191.7, 191.8, 191.9, V10.85; ICD10CM:C71, C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6, C71.7, C71.8, C71.9 | null | null | 32,991,828 | null | MGI | null |
PSS000558 | PGS000626, PGS000627, PGS000628, PGS000629, PGS000630, PGS000632, PGS000634, PGS000635, PGS000636 | 4,270 | 389 | 3,881 | null | null | European | null | USA | null | PheCode:193; ICD9CM:193, V10.87; ICD10CM:C73 | null | null | 32,991,828 | null | MGI | null |
PSS000559 | PGS000637, PGS000638, PGS000639, PGS000640 | 775 | 71 | 704 | null | null | European | null | USA | null | PheCode:201; ICD9CM:201.00, 201.01, 201.02, 201.03, 201.04, 201.05, 201.06, 201.07, 201.08, 201.10, 201.11, 201.12, 201.13, 201.14, 201.15, 201.16, 201.17, 201.18, 201.20, 201.21, 201.22, 201.23, 201.24, 201.25, 201.26, 201.27, 201.28, 201.40, 201.41, 201.42, 201.43, 201.44, 201.45, 201.46, 201.47, 201.48, 201.50, 201.... | null | null | 32,991,828 | null | MGI | null |
PSS000560 | PGS000643, PGS000644 | 3,256 | 296 | 2,960 | null | null | European | null | USA | null | PheCode:202.21; ICD9CM:202.00, 202.01, 202.02, 202.03, 202.04, 202.05, 202.06, 202.07, 202.08; ICD10CM:C82, C82.0, C82.00, C82.01, C82.02, C82.03, C82.04, C82.05, C82.06, C82.07, C82.08, C82.09, C82.1, C82.10, C82.11, C82.12, C82.13, C82.14, C82.15, C82.16, C82.17, C82.18, C82.19, C82.2, C82.20, C82.21, C82.22, C82.23,... | null | null | 32,991,828 | null | MGI | null |
PSS000561 | PGS000646, PGS000648, PGS000650, PGS000651 | 756 | 69 | 687 | null | null | European | null | USA | null | PheCode:204.12; ICD9CM:204.10, 204.11, 204.12; ICD10CM:C91.1, C91.10, C91.11, C91.12 | null | null | 32,991,828 | null | MGI | null |
PSS000562 | PGS000645 | 957 | 87 | 870 | null | null | European | null | USA | null | PheCode:204.1; ICD9CM:204.00, 204.01, 204.02, 204.10, 204.11, 204.12, 204.20, 204.21, 204.22, 204.80, 204.81, 204.82, 204.90, 204.91, 204.92, V10.61; ICD10CM:C91, C91.0, C91.00, C91.01, C91.02, C91.1, C91.10, C91.11, C91.12, C91.3, C91.30, C91.31, C91.32, C91.4, C91.40, C91.41, C91.42, C91.5, C91.50, C91.51, C91.52, C9... | null | null | 32,991,828 | null | MGI | null |
PSS000563 | PGS000652 | 908 | 83 | 825 | null | null | European | null | USA | null | PheCode:204.4; ICD9CM:203.00, 203.01, 203.02, 203.80, 203.81, 203.82; ICD10CM:C88.2, C88.3, C88.9, C90.0, C90.00, C90.01, C90.02, C90.2, C90.20, C90.21, C90.22, C90.30, C90.31, C90.32 | null | null | 32,991,828 | null | MGI | null |
PSS000564 | PGS000368, PGS000370, PGS000371, PGS000372 | 24,996 | 2,271 | 22,725 | null | null | European | null | UK | null | PheCode:153; ICD9:154.8; ICD10:C18.0, C18.1, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C18.9, C19, C20, C21.0, C21.1, C21.8, C26.0, D01.0, D01.1, D01.2, D01.3 | null | null | 32,991,828 | null | UKB | null |
PSS000565 | PGS000385, PGS000386 | 3,591 | 327 | 3,264 | null | null | European | null | UK | null | PheCode:157; ICD9:157, 157.0, 157.1, 157.2, 157.3, 157.4, 157.8, 157.9; ICD10:C25.0, C25.1, C25.2, C25.3, C25.4, C25.7, C25.8, C25.9 | null | null | 32,991,828 | null | UKB | null |
PSS000566 | PGS000390, PGS000392 | 12,201 | 1,109 | 11,092 | null | null | European | null | UK | null | PheCode:165.1; ICD9:162, 162.0, 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 231.2; ICD10:C33, C34.0, C34.1, C34.2, C34.3, C34.8, C34.9, D02.2 | null | null | 32,991,828 | null | UKB | null |
PSS000567 | PGS000422, PGS000424, PGS000426, PGS000428 | 14,482 | 1,317 | 13,165 | null | null | European | null | UK | null | PheCode:172.1; ICD9:-; ICD10:C43.0, C43.1, C43.2, C43.3, C43.4, C43.5, C43.6, C43.7, C43.8, C43.9, D03.0, D03.1, D03.2, D03.3, D03.4, D03.5, D03.6, D03.7, D03.8, D03.9 | null | null | 32,991,828 | null | UKB | null |
PSS000568 | PGS000453, PGS000455, PGS000457, PGS000459 | 60,018 | 5,450 | 54,568 | null | null | European | null | UK | null | PheCode:172.21; ICD9:173, 173.0, 173.1, 173.2, 173.3, 173.4, 173.5, 173.6, 173.7, 173.8, 173.9; ICD10:C44.0, C44.1, C44.2, C44.3, C44.4, C44.5, C44.6, C44.7, C44.8, C44.9 | null | null | 32,991,828 | null | UKB | null |
PSS000569 | PGS000462, PGS000464, PGS000466, PGS000468 | 60,018 | 5,450 | 54,568 | null | null | European | null | UK | null | PheCode:172.22; ICD9:173, 173.0, 173.1, 173.2, 173.3, 173.4, 173.5, 173.6, 173.7, 173.8, 173.9; ICD10:C44.0, C44.1, C44.2, C44.3, C44.4, C44.5, C44.6, C44.7, C44.8, C44.9 | null | null | 32,991,828 | null | UKB | null |
PSS000570 | PGS000486, PGS000488, PGS000490, PGS000492, PGS000494, PGS000496, PGS000498, PGS000500, PGS000502, PGS000504, PGS000506, PGS000508, PGS000510, PGS000512, PGS000518, PGS000520, PGS000522, PGS000524, PGS000526, PGS000528, PGS000530, PGS000532, PGS000534, PGS000536, PGS000538, PGS000540 | 68,531 | 6,242 | 62,289 | null | null | European | null | UK | null | PheCode:174.1; ICD9:233.0; ICD10:C50.0, C50.1, C50.2, C50.3, C50.4, C50.5, C50.6, C50.8, C50.9, D05.1, D05.7, D05.9, Z85.3 | null | null | 32,991,828 | null | UKB | null |
PSS000571 | PGS000541, PGS000542 | 6,987 | 634 | 6,353 | null | null | European | null | UK | null | PheCode:182; ICD9:179, 182, 182.0, 182.1, 182.8, 233.2; ICD10:C54.0, C54.1, C54.2, C54.3, C54.8, C54.9, C55, D07.0 | null | null | 32,991,828 | null | UKB | null |
PSS000572 | PGS000544, PGS000545, PGS000546, PGS000547, PGS000548, PGS000549, PGS000550, PGS000551, PGS000552, PGS000553, PGS000554, PGS000555, PGS000556, PGS000557, PGS000558, PGS000560, PGS000562, PGS000563, PGS000564 | 5,196 | 473 | 4,723 | null | null | European | null | UK | null | PheCode:184.11; ICD9:183.0; ICD10:C56 | null | null | 32,991,828 | null | UKB | null |
PSS000573 | PGS000578, PGS000580, PGS000582, PGS000584, PGS000586, PGS000588 | 32,664 | 3,012 | 29,652 | null | null | European | null | UK | null | PheCode:185; ICD9:185, 233.4; ICD10:C61, D07.5 | null | null | 32,991,828 | null | UKB | null |
PSS000574 | PGS000602, PGS000604 | 1,484 | 135 | 1,349 | null | null | European | null | UK | null | PheCode:187.2; ICD9:186, 186.0, 186.9; ICD10:C62.0, C62.1, C62.9 | null | null | 32,991,828 | null | UKB | null |
PSS000575 | PGS000605, PGS000606 | 5,818 | 529 | 5,289 | null | null | European | null | UK | null | PheCode:189.11; ICD9:189.0; ICD10:C64 | null | null | 32,991,828 | null | UKB | null |
PSS000576 | PGS000611, PGS000613 | 13,530 | 1,229 | 12,301 | null | null | European | null | UK | null | PheCode:189.2; ICD9:233.7, 236.7, 239.4; ICD10:C67.0, C67.1, C67.2, C67.3, C67.4, C67.5, C67.6, C67.7, C67.8, C67.9, D09.0, D41.4 | null | null | 32,991,828 | null | UKB | null |
PSS000577 | PGS000622, PGS000624 | 3,020 | 275 | 2,745 | null | null | European | null | UK | null | PheCode:191.11; ICD9:191, 191.0, 191.1, 191.2, 191.3, 191.4, 191.5, 191.6, 191.7, 191.8, 191.9; ICD10:C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6, C71.7, C71.8, C71.9 | null | null | 32,991,828 | null | UKB | null |
PSS000578 | PGS000618, PGS000619 | 3,110 | 283 | 2,827 | null | null | European | null | UK | null | PheCode:191.1; ICD9:192, 192.0, 192.1, 192.2, 192.3, 192.8, 192.9; ICD10:C70.0, C70.1, C70.9, C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6, C71.7, C71.8, C71.9, C72.0, C72.1, C72.2, C72.3, C72.4, C72.5, C72.8, C72.9 | null | null | 32,991,828 | null | UKB | null |
PSS000579 | PGS000631, PGS000633 | 1,778 | 161 | 1,617 | null | null | European | null | UK | null | PheCode:193; ICD9:193; ICD10:C73 | null | null | 32,991,828 | null | UKB | null |
PSS000580 | PGS000641, PGS000642 | 9,952 | 901 | 9,051 | null | null | European | null | UK | null | PheCode:202.2; ICD9:200, 200.2, 200.8, 202.1, 202.2, 202.8, 202.9; ICD10:B21.1, C82.0, C82.1, C82.2, C82.7, C82.9, C83.0, C83.1, C83.2, C83.3, C83.4, C83.5, C83.6, C83.7, C83.8, C83.9, C84.0, C84.1, C84.2, C84.3, C84.4, C84.5, C85.0, C85.1, C85.7, C85.9, C96.7, C96.9, L41.2 | null | null | 32,991,828 | null | UKB | null |
PSS000581 | PGS000647, PGS000649 | 2,758 | 249 | 2,509 | null | null | European | null | UK | null | PheCode:204.12; ICD9:204.1; ICD10:C91.1 | null | null | 32,991,828 | null | UKB | null |
PSS000582 | PGS000653, PGS000654 | 2,738 | 248 | 2,490 | null | null | European | null | UK | null | PheCode:204.4; ICD9:203, 203.0, 203.8; ICD10:C88.1, C88.3, C88.9, C90.0, C90.2 | null | null | 32,991,828 | null | UKB | null |
PSS000583 | PGS000655 | 9,677 | 1,106 | 8,571 | 42.6 | null | European | null | USA | null | Case inclusion ICD codes: ICD9=571.5, ICD9=571.8, ICD9=571.9, ICD10=K75.81, ICD10=K76.0, ICD10=K76.9 | null | null | null | null | eMERGE | null |
PSS000584 | PGS000655, PGS000656 | 235 | 79 | 156 | null | null | European | null | USA | null | Controls are cases with Nonalcoholic fatty liver disease activity score <5 and cases are those with a score >5. Case inclusion ICD codes: ICD9=571.5, ICD9=571.8, ICD9=571.9, ICD10=K75.81, ICD10=K76.0, ICD10=K76.9 | null | null | null | null | eMERGE | null |
PSS000585 | PGS000657 | 4,741 | null | null | 47.5 | mean:55.8;sd:7.6;unit:years | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS000585 | PGS000657 | 6,704 | null | null | 49.3 | mean:62.6;sd:9.9;unit:years | European, NR | null | Canada | null | null | null | null | null | null | CLSA | null |
PSS000585 | PGS000657 | 3,426 | null | null | 0 | mean:71.5;sd:5.3;unit:years | European, NR | null | USA | null | null | null | null | null | null | SOF | null |
PSS000585 | PGS000657 | 4,657 | null | null | 100 | mean:74.0;sd:6.0;unit:years | European | null | USA | null | null | null | null | null | null | MrOS-USA | null |
PSS000585 | PGS000657 | 1,880 | null | null | 100 | mean:75.4;sd:3.2;unit:years | European | Swedish | Sweden | null | null | null | null | null | null | MrOS-SWE | null |
PSS000586 | PGS000657 | 80,027 | null | null | 47.5 | mean:55.8;sd:7.6;unit:years | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS000587 | PGS000658, PGS000659, PGS000660 | 426 | null | null | 46 | mean:43.3;sd:11.4;unit:years | East Asian | Chinese | Hong Kong | null | Measured using fasting blood samples | null | null | 16,718,283 | null | null | Adults |
PSS000588 | PGS000661 | 426 | null | null | 46 | mean:43.3;sd:11.4;unit:years | East Asian | Chinese | Hong Kong | null | Derived from the Friedewald’s formula | null | null | 16,718,283 | null | null | Adults |
PSS000589 | PGS000658, PGS000659, PGS000660 | 1,941 | null | null | 57.7 | mean:58.2;sd:12.34;unit:years | East Asian | Chinese | Hong Kong | null | Measured using fasting blood samples | null | null | 32,722,720 | null | HKDB | null |
PSS000590 | PGS000661 | 1,941 | null | null | 57.7 | mean:58.2;sd:12.34;unit:years | East Asian | Chinese | Hong Kong | null | Derived from the Friedewald’s formula | null | null | 32,722,720 | null | HKDB | null |
PSS000591 | PGS000658, PGS000659, PGS000660 | 865 | null | null | 57.6 | mean:57.0;sd:12.08;unit:years | East Asian | Chinese | Hong Kong | null | Measured using fasting blood samples | null | null | 32,722,720 | null | HKDB | null |
PSS000592 | PGS000661 | 865 | null | null | 57.6 | mean:57.0;sd:12.08;unit:years | East Asian | Chinese | Hong Kong | null | Derived from the Friedewald’s formula | null | null | 32,722,720 | null | HKDB | null |
PSS000593 | PGS000658, PGS000659, PGS000660 | 4,917 | null | null | 44.9 | mean:56.3;sd:13.5;unit:years | East Asian | Chinese | Hong Kong | null | Measured using fasting blood samples | null | null | 30,415,941 | null | HKDR | null |
PSS000594 | PGS000661 | 4,917 | null | null | 44.9 | mean:56.3;sd:13.5;unit:years | East Asian | Chinese | Hong Kong | null | Derived from the Friedewald’s formula | null | null | 30,415,941 | null | HKDR | null |
PSS000595 | PGS000662 | 2,633 | 1,586 | 1,047 | 100 | null | African unspecified | null | USA, Uganda | null | null | null | null | null | null | CAUG | null |
PSS000596 | PGS000662 | 199,969 | 6,852 | 193,117 | 100 | null | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS000597 | PGS000663 | 956 | 304 | 652 | 28.1 | null | European | null | null | null | In this study, cases were incident patients with primary pancreatic adenocarcinoma ascertained between 1984 and 2010 through self- report, report of next-of-kin, or death certificates and confirmed by medical record review and tumor registry data. Cases Diagnosed within 10 years of blood collection. | mean:10.0;unit:years | null | null | null | HPFS|NHS|PHS|WHI | Overlap with GWAS samples (percentage unknown). Cross validation approach used (20% as testing sample) |
PSS000598 | PGS000663 | 1,591 | 500 | 1,091 | 33.4 | null | European | null | null | null | In this study, cases were incident patients with primary pancreatic adenocarcinoma ascertained between 1984 and 2010 through self- report, report of next-of-kin, or death certificates and confirmed by medical record review and tumor registry data. | null | null | null | null | HPFS|NHS|PHS|WHI | Overlap with GWAS samples (percentage unknown). Cross validation approach used (20% as testing sample) |
PSS000599 | PGS000664 | 3,447 | 1,013 | 2,434 | null | null | European | null | null | null | Cases: ICD 10 code N17. Controls: no ICD10 code N17, frequency-matched by age-group and sex | null | null | null | null | UKB | Possible overlap between GWAS cohorts and this dataset. |
PSS000600 | PGS000664 | 11,440 | 448 | 10,992 | null | null | European | null | null | null | CKDi25 cases defined as >25% eGFRcrea decline during follow-up together with a movement from eGFRcrea≥60 mL/min/1.73m^2 at baseline to eGFR<60 mL/min/1.73m^2 at follow up compared to CKDi25 controls defined as eGFRcrea≥60 mL/min/1.73m^2. High risk groups had 8-14 adverse alleles. Low risk groups had 0-5 adverse alleles... | null | null | null | null | UKB|DIACORE|KORA | 87.61% overlap between the CKDi25 GWAS cohort and this dataset. |
PSS000601 | PGS000665 | 11,187 | 395 | 10,792 | 60.78 | mean:70.8;sd:9.1;unit:years | European | null | null | null | All patients with atrial fibrillation and CHADS2 score of 2 or higher who were treated with anticoagulation. The endpoint of interest was ischemic stroke. In each trial, ischemic stroke was formally adjudicated by an independent clinical endpoint committee blinded to treatment assignment. | median:2.8;unit:years | null | null | null | ENGAGE_AF-TIMI_48 | null |
PSS000602 | PGS000665 | 51,288 | 960 | 50,328 | 71.7 | mean:65.9;sd:9.2;unit:years | European | null | null | null | The endpoint of interest was ischemic stroke. In each trial, ischemic stroke was formally adjudicated by an independent clinical endpoint committee blinded to treatment assignment. | median:2.5;unit:years | null | null | null | ENGAGE_AF-TIMI_48|SOLID-TIMI_52|SAVOR-TIMI_53|PEGASUS-TIMI_54|FOURIER | null |
PSS000603 | PGS000666 | 449,027 | 923 | 448,104 | null | null | NR | null | null | null | Hospitalization for or death due to ICD-10 code for dilated cardiomyopathy (I42.0); excluding individuals with history of coronary artery disease (as defined below), or history of hypertrophic cardiomyopathy during verbal interview with trained nurse, or hospitalization for or death due to ICD-10 code for hypertrophic ... | null | null | null | null | UKB | null |
PSS000604 | PGS000666 | 362,922 | 380 | 362,542 | 45 | mean:57.0;sd:8.1;unit:years | European, South Asian, African unspecified, East Asian, NR | null | null | African unspecified = 2937, East Asain = 1303, European = 348778, NR = 3670, South Asian =6234 | Incident DCM: Hospitalization for or death due to ICD-10 code for dilated cardiomyopathy (I42.0); excluding individuals with history of coronary artery disease (as defined below), or history of hypertrophic cardiomyopathy during verbal interview with trained nurse, or hospitalization for or death due to ICD-10 code for... | null | null | null | null | UKB | null |
PSS000605 | PGS000667 | 113,703 | 5,938 | 107,765 | null | null | European | null | null | null | This subgroup included individuals with complete and imputed data and were classified as having borderline-intermediate ASCVD risk (defined by the Pooled Cohorts Equation) without prevalent ASCVD, diabetes mellitus, severe hypercholesterolemia, or use of cholesterol-lowering medication (10-year risk of 5-20%). Cases i... | median:11.1;unit:years | null | null | null | UKB | null |
PSS000606 | PGS000667 | 144,350 | 5,505 | 138,845 | null | null | European | null | null | null | This subgroup included individuals with complete and imputed data and were classified as having borderline-intermediate ASCVD risk (defined by QRISK3) without prevalent ASCVD, diabetes mellitus, severe hypercholesterolemia, or use of cholesterol-lowering medication (10-year risk of 5-20%). Cases included individuals wh... | median:11.1;unit:years | null | null | null | UKB | null |
PSS000607 | PGS000667 | 283,540 | 7,771 | 275,769 | null | null | European | null | null | null | At the time of enrollment, particpants were without ASCVD. Participants were not using cholesterol-lowering medication. Coronary artery disease defined as: ICD-9 (410, 411, 412, 42979), ICD-10 (I21, I22, I23, I24.1, I25.2) and OCPS-4 (K40, K41, K42, K43, K44, K45, K46, K47, K48, K49, K50 and K75) | median:11.1;unit:years | null | null | null | UKB | null |
PSS000608 | PGS000667 | 283,540 | 3,539 | 280,001 | null | null | European | null | null | null | At the time of enrollment, particpants were without ASCVD. Participants were not using cholesterol-lowering medication. Cardiovascular mortality defined as: ICD-10 (any diagnosis code for causes of death related to chapter IX diseases of the circulatory system). | median:11.1;unit:years | null | null | null | UKB | null |
PSS000609 | PGS000667 | 283,540 | 5,666 | 277,874 | null | null | European | null | null | null | At the time of enrollment, particpants were without ASCVD. Participants were not using cholesterol-lowering medication. Myocardial infarction defined as: ICD-9 (410, 411, 412, 42979) and ICD-10 (I21, I22, I23, I24.1, I25.2). | median:11.1;unit:years | null | null | null | UKB | null |
PSS000610 | PGS000667 | 283,540 | 2,283 | 281,257 | null | null | European | null | null | null | At the time of enrollment, particpants were without ASCVD. Participants were not using cholesterol-lowering medication. Peripheral artery disease (non-coronary or cerebrovascular events) defined as: ICD-9 (440, 444, 4438, 4439), ICD-10 (I70, I74, I73.8, I73.9) and OCPS-4 (L50, L51, L52, L54, L58, L59, L60, L63, X09). | median:11.1;unit:years | null | null | null | UKB | null |
PSS000611 | PGS000667 | 283,540 | 14,697 | 268,843 | null | null | European | null | null | null | At the time of enrollment, particpants were without ASCVD. Participants were not using cholesterol-lowering medication. The outcomes of myocardial infarction, coronary artery disease, ischemic stroke, peripheral arterial disease, cardiovascular mortality, and a composite of the aforementioned outcomes were based on Int... | median:11.1;unit:years | null | null | null | UKB | null |
PSS000612 | PGS000667 | 283,540 | 2,938 | 280,602 | null | null | European | null | null | null | At the time of enrollment, particpants were without ASCVD. Participants were not using cholesterol-lowering medication. Ischemic stroke defined as: ICD-9 (434, 436) and ICD-10 (I63, I64) | median:11.1;unit:years | null | null | null | UKB | null |
PSS000613 | PGS000667 | 6,521 | null | null | null | null | African unspecified | null | null | null | The outcomes of myocardial infarction, coronary artery disease, ischemic stroke, peripheral arterial disease, cardiovascular mortality, and a composite of the aforementioned outcomes were based on International Statistical Classification of Diseases and Related Health Problems and Office of Population Censuses and Surv... | null | null | null | null | UKB | null |
PSS000614 | PGS000667 | 2,774 | null | null | null | null | East Asian | null | null | null | The outcomes of myocardial infarction, coronary artery disease, ischemic stroke, peripheral arterial disease, cardiovascular mortality, and a composite of the aforementioned outcomes were based on International Statistical Classification of Diseases and Related Health Problems and Office of Population Censuses and Surv... | null | null | null | null | UKB | null |
PSS000615 | PGS000667 | 350,903 | null | null | null | null | European | null | null | null | The outcomes of myocardial infarction, coronary artery disease, ischemic stroke, peripheral arterial disease, cardiovascular mortality, and a composite of the aforementioned outcomes were based on International Statistical Classification of Diseases and Related Health Problems and Office of Population Censuses and Surv... | null | null | null | null | UKB | null |
PSS000616 | PGS000667 | 6,203 | null | null | null | null | South Asian | null | null | null | The outcomes of myocardial infarction, coronary artery disease, ischemic stroke, peripheral arterial disease, cardiovascular mortality, and a composite of the aforementioned outcomes were based on International Statistical Classification of Diseases and Related Health Problems and Office of Population Censuses and Surv... | null | null | null | null | UKB | null |
PSS000617 | PGS000674 | 5,981 | null | null | null | null | African unspecified | null | UK | null | null | null | null | null | null | UKB | null |
PSS000618 | PGS000674 | 1,069 | null | null | null | null | East Asian | null | UK | null | null | null | null | null | null | UKB | null |
PSS000619 | PGS000674 | 23,478 | null | null | null | null | European | null | UK | Non-British White | null | null | null | null | null | UKB | null |
PSS000620 | PGS000674 | 7,309 | null | null | null | null | South Asian | null | UK | null | null | null | null | null | null | UKB | null |
PSS000621 | PGS000674 | 63,545 | null | null | null | null | European | British | UK | null | null | null | null | null | null | UKB | null |
PSS000622 | PGS000668 | 6,017 | null | null | null | null | African unspecified | null | UK | null | null | null | null | null | null | UKB | null |
PSS000623 | PGS000668 | 1,081 | null | null | null | null | East Asian | null | UK | null | null | null | null | null | null | UKB | null |
PSS000624 | PGS000668 | 23,569 | null | null | null | null | European | null | UK | Non-British White | null | null | null | null | null | UKB | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.